Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 9.61
4.12 %
$ 11.5 B
Market Cap
-18.13
P/E
Price Target
Average
38.25%
Revenue Forecast
Estimate
3.62%
EBIT
Estimate
25.25%
Net Income
Estimate
652.77%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Viatris Inc.
Wall Street analysts predict an average 1-year price target for VTRS of $13.3 , with forecasts ranging from
a
low of
$10 to a high of $15 .
VTRS Lowest Price Target
Wall Street Target
10 USD
4.06%
VTRS Average Price Target
Wall Street Target
13.3 USD
38.25%
VTRS Highest Price Target
Wall Street Target
15 USD
56.09%
REVENUE FORECAST
Revenue Forecast Chart VTRS
EBIT FORECAST
EBIT Forecast Chart VTRS
NET INCOME FORECAST
Net Income Chart VTRS